IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2008;49:2993-3003.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-0919

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polak, M. B.
Right arrow Articles by Behar-Cohen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polak, M. B.
Right arrow Articles by Behar-Cohen, F.

Controlled Delivery of 5-Chlorouracil Using Poly(Ortho Esters) in Filtering Surgery for Glaucoma

Marianne Berdugo Polak,1 Fatemeh Valamanesh,1,2 Olivia Felt,3 Alicia Torriglia,1 Jean-Claude Jeanny,1 Jean-Louis Bourges,1,4 Patrice Rat,5 Aoife Thomas-Doyle,1 David BenEzra,1,6 Robert Gurny,3 and Francine Behar-Cohen1,4

1From the Inserm UMRS 872 Team 17, Centre de Recherche des Cordeliers, Paris, France; 2A. de Rothschild Ophthalmic Foundation, Paris, France; 3Department of Pharmaceutical Technology and Biopharmaceutics, School of Pharmacy, University of Geneva, Switzerland; 4Department of Ophthalmology, Hotel-Dieu Hospital, Paris, France; 5Department of Toxicology, Pharmaceutical and Biological Sciences University, Paris Descartes University, Paris, France; and 6Hadassah Hebrew University, Jerusalem, Israel.

PURPOSE. To evaluate the antimitotic and toxic effects of 5-chlorouracil (5-CU) and 5-fluorouracil (5-FU) and study their potential to delay filtering bleb closure in the rabbit eye when released by poly(ortho esters) (POE).

METHODS. Rabbit Tenon fibroblasts and human conjunctival cells were incubated with various 5-CU and 5-FU concentrations. Antiproliferative effects and toxicity were evaluated at 24 and 72 hours by monotetrazolium, neutral red, and Hoechst tests and cell counting. Mechanisms of cell death were evaluated using TUNEL assay, annexin V binding, immunohistochemistry for anti–apoptosis-inducing factor (AIF) and LEI/L-DNase II. Trabeculectomy was performed in pigmented rabbits. Two hundred microliters of POE loaded with 1% wt/wt 5-FU or 5-CU was injected into the subconjunctival space after surgery. Intraocular pressure (IOP) and bleb persistence were monitored for 150 days.

RESULTS. In vitro, 5-FU showed a higher antiproliferative effect and a more toxic effect than 5-CU. 5-FU induced cell necrosis, whereas 5-CU induced mostly apoptosis. The apoptosis induced by 5-CU was driven through a non-caspase–dependent pathway involving AIF and LEI/L-DNase II. In vivo, at 34 days after surgery, the mean IOP in the POE/5-CU–treated group was 83% of the baseline level and only 40% in the POE/5-FU–treated group. At 100 days after surgery, IOP was still decreased in the POE/5-CU group when compared with the controls and still inferior to the preoperative value. The mean long-term IOP, with all time points considered, was significantly (P < 0.0001) decreased in the POE/5-CU–treated group (6.0 ± 2.4 mm Hg) when compared with both control groups, the trabeculectomy alone group (7.6 ± 2.9 mm Hg), and the POE alone group (7.5 ± 2.6 mm Hg). Histologic analysis showed evidence of functioning blebs in the POE-5-CU–treated eyes along with a preserved structure of the conjunctiva epithelium.

CONCLUSIONS. The slow release of 5-CU from POE has a longstanding effect on the decrease of IOP after glaucoma-filtering surgery in the rabbit eye. Thus, the slow release of POE/5-CU may be beneficial for the prevention of bleb closure in patients who undergo complicated trabeculectomy.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology